Radboud University Medical Center: Lung Neoplasms trials

The registry lists 14 Lung Neoplasms studies with Radboud University Medical Center as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 3Phase 4 3No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer PatientsRecruitingNCT06082492Not applicable
• Validation of Rapid On-site Diagnostics in Early Stage Lung Cancer Sampling With a Higher Harmonic Generation MicroscopeRecruitingNCT06007261
• Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify TDLN in Early-stage NSCLCCompletedNCT05555199Not applicable
• Imaging Tumor-infiltrating T-cells in Non-small Cell Lung CancerCompletedNCT03853187Phase 2
• Dose Individualization of Pemetrexed - IMPROVE-ICompletedNCT03656549Phase 4
• Dose Individualization of Pemetrexed - IMPROVE-IIICompletedNCT03655834Phase 4
• Dose Individualization of Pemetrexed - IMPROVE-IITerminatedNCT03655821Phase 4
• PD-L1 Imaging in Non Small Cell Lung Cancer' (PINNACLE)CompletedNCT03514719Phase 1
• E- Predict: EBUS ELASTOGRAPHY STRAIN in Lung CancerCompletedNCT02488928
• HD+ I-scan Bronchoscopy Vascular Abnormalities Detection Multicenter StudyCompletedNCT02285426
• Treatment of Early Stage Lung Cancer by VATS Versus OPEN LobectomyStatus unknownNCT01933828Not applicable
• Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)RadiotherapyTerminatedNCT01577212Phase 2
• Mindfulness for Lung Cancer Patients and PartnersCompletedNCT01494883Not applicable
• Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic TherapyCompletedNCT00702975Phase 2